MARKSANSPharmaceuticals
Marksans Pharma Ltd — Balance Sheet
₹156.89
-1.28%
Marksans Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 45.32 Cr | 45.32 Cr | 44.67 Cr | 40.93 Cr | — |
| Share Issued | 45.32 Cr | 45.32 Cr | 45.32 Cr | 40.93 Cr | — |
| Total Debt | 321.91 Cr | 244.06 Cr | 122.94 Cr | 110.78 Cr | — |
| Tangible Book Value | 2.35K Cr | 1.96K Cr | 1.64K Cr | 1.11K Cr | — |
| Invested Capital | 2.49K Cr | 2.09K Cr | 1.79K Cr | 1.24K Cr | — |
| Working Capital | 1.73K Cr | 1.47K Cr | 1.33K Cr | 844.98 Cr | — |
| Net Tangible Assets | 2.35K Cr | 1.96K Cr | 1.64K Cr | 1.11K Cr | — |
| Capital Lease Obligations | 298.82 Cr | 214.97 Cr | 81.36 Cr | 69.49 Cr | — |
| Common Stock Equity | 2.47K Cr | 2.07K Cr | 1.75K Cr | 1.20K Cr | — |
| Total Capitalization | 2.47K Cr | 2.07K Cr | 1.75K Cr | 1.20K Cr | — |
| Total Equity Gross Minority Interest | 2.49K Cr | 2.09K Cr | 1.77K Cr | 1.22K Cr | — |
| Minority Interest | 22.47 Cr | 20.85 Cr | 19.91 Cr | 20.70 Cr | — |
| Stockholders Equity | 2.47K Cr | 2.07K Cr | 1.75K Cr | 1.20K Cr | — |
| Other Equity Interest | 2.42K Cr | 2.02K Cr | 1.70K Cr | 93.10 Cr | — |
| Retained Earnings | 1.42K Cr | 1.07K Cr | 777.60 Cr | 509.31 Cr | — |
| Additional Paid In Capital | 518.64 Cr | 518.64 Cr | 518.64 Cr | 181.69 Cr | — |
| Capital Stock | 45.32 Cr | 45.32 Cr | 45.32 Cr | 40.93 Cr | — |
| Common Stock | 45.32 Cr | 45.32 Cr | 45.32 Cr | 40.93 Cr | — |
| Total Liabilities Net Minority Interest | 750.25 Cr | 595.05 Cr | 425.32 Cr | 417.13 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 272.91 Cr | 205.20 Cr | 84.33 Cr | 60.91 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 5.92 Cr | 4.56 Cr | — | — | — |
| Non Current Deferred Taxes Liabilities | 3.66 Cr | 10.62 Cr | 15.39 Cr | 17.62 Cr | — |
| Long Term Debt And Capital Lease Obligation | 263.33 Cr | 190.02 Cr | 65.69 Cr | 41.43 Cr | — |
| Long Term Capital Lease Obligation | 263.33 Cr | 190.02 Cr | 65.69 Cr | 41.43 Cr | — |
| Long Term Provisions | 5.92 Cr | 4.56 Cr | 3.25 Cr | 1.86 Cr | — |
| Current Liabilities | 477.34 Cr | 389.85 Cr | 340.99 Cr | 356.22 Cr | — |
| Other Current Liabilities | 58.03 Cr | 0.90 Cr | 0.84 Cr | 54.40 Cr | — |
| Current Deferred Taxes Liabilities | 29.94 Cr | 19.91 Cr | 25.28 Cr | 17.33 Cr | — |
| Current Debt And Capital Lease Obligation | 58.58 Cr | 54.04 Cr | 57.26 Cr | 69.34 Cr | — |
| Current Capital Lease Obligation | 35.49 Cr | 24.95 Cr | 15.67 Cr | 28.05 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 1.45 Cr | 1.96 Cr | 1.33 Cr | 0.72 Cr | — |
| Current Provisions | 1.45 Cr | 1.96 Cr | 1.33 Cr | 0.72 Cr | — |
| Payables | 381.17 Cr | 310.92 Cr | 251.63 Cr | 212.69 Cr | — |
| Other Payable | 75.08 Cr | 42.30 Cr | 20.77 Cr | 12.38 Cr | — |
| Dividends Payable | 0.39 Cr | 0.34 Cr | 0.26 Cr | 0.23 Cr | — |
| Total Tax Payable | 29.94 Cr | 19.91 Cr | 25.28 Cr | 17.33 Cr | — |
| Accounts Payable | 305.70 Cr | 268.28 Cr | 230.60 Cr | 200.08 Cr | — |
| Total Assets | 3.24K Cr | 2.68K Cr | 2.19K Cr | 1.64K Cr | — |
| Total Non Current Assets | 1.04K Cr | 818.46 Cr | 515.09 Cr | 438.90 Cr | — |
| Other Non Current Assets | 21.76 Cr | 29.38 Cr | 14.57 Cr | 1.55 Cr | — |
| Non Current Prepaid Assets | 21.83 Cr | 20.81 Cr | 12.96 Cr | 2.61 Cr | — |
| Investmentin Financial Assets | 0.01 Cr | 0.01 Cr | 0.00 | 2.61 Cr | — |
| Available For Sale Securities | 0.01 Cr | 0.01 Cr | 3.48 Cr | 2.61 Cr | — |
| Goodwill And Other Intangible Assets | 113.66 Cr | 104.26 Cr | 109.29 Cr | 88.59 Cr | — |
| Other Intangible Assets | 72.73 Cr | 64.76 Cr | 70.80 Cr | 58.57 Cr | — |
| Goodwill | 40.93 Cr | 39.50 Cr | 38.49 Cr | 30.02 Cr | — |
| Net PPE | 899.85 Cr | 693.22 Cr | 392.84 Cr | 343.84 Cr | — |
| Accumulated Depreciation | -351.10 Cr | -293.07 Cr | -236.29 Cr | -204.41 Cr | — |
| Gross PPE | 1.25K Cr | 986.29 Cr | 629.13 Cr | 548.25 Cr | — |
| Construction In Progress | 13.44 Cr | 17.51 Cr | 13.20 Cr | 2.25 Cr | — |
| Other Properties | 18.57 Cr | 17.72 Cr | 379.64 Cr | 341.59 Cr | — |
| Machinery Furniture Equipment | 571.29 Cr | 445.42 Cr | 344.86 Cr | 318.83 Cr | — |
| Buildings And Improvements | 624.67 Cr | 482.69 Cr | 269.59 Cr | 225.74 Cr | — |
| Land And Improvements | 22.97 Cr | 22.96 Cr | 1.48 Cr | 1.43 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 2.20K Cr | 1.86K Cr | 1.68K Cr | 1.20K Cr | — |
| Other Current Assets | 97.79 Cr | 12.02 Cr | 0.39 Cr | 2.52 Cr | — |
| Hedging Assets Current | 0.00 | 0.11 Cr | 0.00 | 7.06 Cr | — |
| Restricted Cash | 43.38 Cr | 33.90 Cr | 25.77 Cr | 3.01 Cr | — |
| Prepaid Assets | 56.22 Cr | 46.47 Cr | 27.62 Cr | 18.33 Cr | — |
| Inventory | 845.52 Cr | 617.94 Cr | 484.74 Cr | 424.44 Cr | — |
| Finished Goods | 508.24 Cr | 330.86 Cr | 261.34 Cr | 262.81 Cr | — |
| Work In Process | 31.17 Cr | 24.80 Cr | 20.45 Cr | 10.70 Cr | — |
| Raw Materials | 306.10 Cr | 262.29 Cr | 202.94 Cr | 150.94 Cr | — |
| Other Receivables | 2.14 Cr | 5.74 Cr | 2.93 Cr | 1.31 Cr | — |
| Taxes Receivable | 12.26 Cr | 4.92 Cr | 1.92 Cr | 3.06 Cr | — |
| Accounts Receivable | 540.04 Cr | 453.18 Cr | 416.85 Cr | 394.78 Cr | — |
| Allowance For Doubtful Accounts Receivable | -6.53 Cr | -5.27 Cr | -3.71 Cr | -2.70 Cr | — |
| Gross Accounts Receivable | 546.58 Cr | 458.44 Cr | 420.56 Cr | 397.48 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 704.56 Cr | 700.23 Cr | 715.08 Cr | 346.69 Cr | — |
| Other Short Term Investments | 208.77 Cr | 296.95 Cr | 332.65 Cr | 140.29 Cr | — |
| Cash And Cash Equivalents | 495.79 Cr | 403.28 Cr | 382.44 Cr | 206.41 Cr | — |
| Cash Equivalents | 217.21 Cr | 251.21 Cr | 294.91 Cr | 49.72 Cr | — |
| Cash Financial | 278.57 Cr | 152.07 Cr | 87.52 Cr | 156.69 Cr | — |
| Current Debt | 23.09 Cr | 29.09 Cr | 41.59 Cr | 41.29 Cr | — |
| Treasury Shares Number | — | 0.00 | 0.65 Cr | — | — |
| Non Current Deferred Taxes Assets | — | — | 0.00 | 3.86 Cr | 0.80 Cr |
| Preferred Securities Outside Stock Equity | — | — | — | 0.00 | 5.00 Cr |
| Long Term Debt | — | — | — | 0.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Marksans Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.